Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginNet MarginOperating MarginReturn on Sales

ProQR Therapeutics (PRQR) Return on Assets (2021 - 2023)

Historic Return on Assets for ProQR Therapeutics (PRQR) over the last 3 years, with Q4 2023 value amounting to 0.23%.

  • ProQR Therapeutics' Return on Assets rose 2300.0% to 0.23% in Q4 2023 from the same period last year, while for Dec 2023 it was 0.23%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.18% for FY2024, which is 0.0% changed from last year.
  • As of Q4 2023, ProQR Therapeutics' Return on Assets stood at 0.23%, which was up 2300.0% from 0.26% recorded in Q3 2023.
  • ProQR Therapeutics' 5-year Return on Assets high stood at 0.23% for Q4 2023, and its period low was 0.48% during Q3 2022.
  • Over the past 3 years, ProQR Therapeutics' median Return on Assets value was 0.32% (recorded in 2022), while the average stood at 0.34%.
  • Per our database at Business Quant, ProQR Therapeutics' Return on Assets tumbled by -1700bps in 2022 and then surged by 2300bps in 2023.
  • ProQR Therapeutics' Return on Assets (Quarter) stood at 0.29% in 2021, then plummeted by -61bps to 0.46% in 2022, then skyrocketed by 51bps to 0.23% in 2023.
  • Its last three reported values are 0.23% in Q4 2023, 0.26% for Q3 2023, and 0.32% during Q2 2023.